CD4 and AIDS: To address these issues, we developed a HLA-mismatched allogeneic adoptive immune therapy (AAIT) combined with ART regimen specifically tailored for severely immunosuppressed AIDS patients with CD4+ T-cell counts <50 cells/μl.